Li Luo
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
Li Luo
58 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Biomaterials 308
- Cancer Research 225
- Molecular Biology 773
- Immunology 212
- Obstetrics and Gynecology 66
Countries citing papers authored by Li Luo
This map shows the geographic impact of Li Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Luo more than expected).
Fields of papers citing papers by Li Luo
This network shows the impact of papers produced by Li Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Luo. The network helps show where Li Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 18 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 29 | |
| 12 | 2023 | 10 | |
| 13 | 2021 | 53 | |
| 14 | 2019 | 119 | |
| 15 | 2019 | 9 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 5 | |
| 18 | [Research progress on seroepidemiological study of enterovirus 71 and coxsackievirus A16 infection among children]. | 2015 | 3 |
| 19 | 2015 | 6 | |
| 20 | 2005 | 75 |
About Li Luo
Li Luo is a scholar working on Obstetrics and Gynecology, Microbiology, Reproductive Medicine, Biomaterials and Applied Psychology, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (4 papers), Endometriosis Research and Treatment (4 papers), Extracellular vesicles in disease (4 papers), Mitochondrial Function and Pathology (3 papers), Viral gastroenteritis research and epidemiology (3 papers) and Bone Tissue Engineering Materials (3 papers). The work is most often cited by research in Biomaterials (308 citations), Cancer Research (225 citations), Molecular Biology (773 citations), Immunology (212 citations) and Obstetrics and Gynecology (66 citations). Li Luo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wei Wu, Yi Wang, Guixue Wang, Xian Qin, Yuan Zhong, Ali Maruf, Juhui Qiu, John Antoniou, Fackson Mwale and Tianhan Li. Their work appears in journals such as Theranostics, Nature Communications, Cochrane Database of Systematic Reviews, Biomaterials and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.